文献速递前列腺癌

根治性前列腺切除术后18F-DCFPyL前列腺特异性膜抗原阳性复发的病理预测因素

Pathological predictors of 18 F-DCFPyL prostate-specific membrane antigen-positive recurrence after radical prostatectomy.
PubMed 文献 · BJU Int · 2022-01-01

该回顾性分析纳入澳大利亚和新西兰中心205例根治性前列腺切除术后生化失败患者,评估病理特征与PSA参数同18F-DCFPyL PET/CT表现的相关性。120例(58.5%)出现符合复发性前列腺癌的PSMA异常表达。PSA速度增高、ISUP分级分组、淋巴血管侵犯及淋巴结阳性与PSMA阳性相关;多变量分析显示PSMA PET/CT前较高PSA水平、Gleason评分≥8及淋巴结阳性为PSMA阳性的预测因素。

要点

  • 205例RP后生化失败患者中120例(58.5%)18F-DCFPyL PET/CT提示PSMA阳性复发。
  • PSA速度增高(P=0.01)、ISUP分级分组(P=0.02)、淋巴血管侵犯(P=0.05)及淋巴结阳性(P=0.02)与PSMA阳性相关。
  • 多变量分析显示PSMA PET/CT前较高PSA水平(P<0.01)、Gleason评分≥8(P<0.01)及淋巴结阳性(P=0.05)预测PSMA阳性。

核心结论

  • 18F-DCFPyL PET/CT阳性(总体及部位特异性)与PSA及根治性前列腺切除标本病理因素相关。
  • 作者认为,纳入「PSMA阳性复发」风险因素的列线图可能提高对疾病局限于前列腺床或盆腔、无病生存期延长概率较大患者的识别。

研究设计与样本

  • 回顾性分析澳大利亚和新西兰中心联合18F-DCFPyL PET/CT数据库。
  • 纳入205例根治性前列腺切除术后生化失败患者。

主要发现

  • 205例中120例(58.5%)有符合复发性前列腺癌的PSMA异常表达证据。
  • PSA速度增高(P=0.01)、ISUP分级分组(P=0.02)、淋巴血管侵犯(P=0.05)及淋巴结阳性(P=0.02)者更可能显示PSMA阳性。
  • 多变量logistic回归显示PSMA PET/CT前较高PSA水平(P<0.01)、辅助放疗(P=0.09)、Gleason评分≥8(P<0.01)及淋巴结阳性(P=0.05)均预测PSMA阳性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the correlation of pathological radical prostatectomy (RP) specimen features and prostate-specific antigen (PSA) characteristics to imaging findings on subsequent 18 F-DCFPyL positron emission tomography/computed tomography (PET/CT) in patients with biochemical failure (BF). PATIENTS AND METHODS: Retrospective analysis of combined 18 F-DCFPyL PET/CT database of patients from centres in Australia and New Zealand was performed. A total of 205 patients presenting with BF after RP were included in this study. Imaging findings on 18 F-DCFPyL PET/CT were recorded and correlated with the PSA characteristics at BF and pathological features of the original tumour. RESULTS: Of the 205 patients, 120 (58.5%) had evidence of abnormal prostate-specific membrane antigen (PSMA) expression compatible with recurrent prostate cancer. Increasing PSA velocity (P = 0.01), International Society of Urological Pathology (ISUP) Grade Group (P = 0.02), lymphovascular invasion (P = 0.05) and nodal positivity (P = 0.02) at the time of RP were more likely to demonstrate PSMA positivity. Multivariable logistic regression revealed a higher PSA level prior to PSMA PET/CT (P < 0.01), adjuvant radiotherapy (P = 0.09), Gleason score ≥8 (P < 0.01) and nodal positivity (P = 0.05) were all predictive of PSMA positivity. CONCLUSION: 18 F-DCFPyL PET/CT positivity, both generally and site specific, correlates with PSA and RP pathological factors. Our results echo cohorts focussing on post-RP patients, those imaged with 68 Ga-PSMA and those concerning biochemical persistence. Nomograms that include risk factors for 'PSMA-positive recurrence' in the BF population may increase the catchment of patients with disease confined to the prostate bed or pelvis who have a greater probability of prolonged disease-free survival.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Perry E, Talwar A, Taubman K, et al. Pathological predictors of 18 F-DCFPyL prostate-specific membrane antigen-positive recurrence after radical prostatectomy. BJU Int. 2022. PMID: 35768883. doi:10.1111/bju.15724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。